The present invention pertains to a pharmaceutical composition comprising thecompound of the formula (I) in a high concentration and at least onepharmaceutically acceptable excipient, the use of the composition for thetreatment of hyper-proliferative diseases, such as cancer, either as a soleagent, or in combination with other anti-cancer therapies, and the process forpreparing of said composition.
